Hypoxia-selective macroautophagy and cell survival signaled by autocrine PDGFR activity

Simon Wilkinson1, Jim O'Prey, Michael Fricker

  • 1Tumour Cell Death Laboratory, Beatson Institute for Cancer Research, Glasgow, United Kingdom.

Genes & Development
|June 3, 2009
PubMed

Insights

Platelet-derived growth factor receptor (PDGFR) signaling promotes hypoxia-induced macroautophagy in tumor cells. This process involves HIF1alpha, crucial for tumor cell survival under low oxygen conditions.

Area of Science:

  • Cell Biology
  • Molecular Oncology
  • Cancer Research

Background:

  • Selective regulation of macroautophagy is not well understood.
  • Macroautophagy plays a role in tumor cell survival.

Purpose of the Study:

  • To investigate the role of PDGFR signaling in hypoxia-induced macroautophagy.
  • To elucidate the mechanism by which PDGFR signaling influences HIF1alpha and macroautophagy.

Main Methods:

  • Investigated PDGFR signaling in tumor cells under hypoxic conditions.
  • Analyzed the impact of PDGFR inhibition on HIF1alpha levels and macroautophagy.
  • Examined HIF1alpha mRNA and protein dynamics.

Main Results:

  • PDGFR signaling selectively promotes hypoxia-induced macroautophagy.
  • HIF1alpha integrates signals from PDGFRs and oxygen tension.
  • PDGFR inhibition reduces HIF1alpha half-life, altering its transcriptome and reducing macroautophagy.

Conclusions:

  • PDGFR signaling is essential for promoting macroautophagy during hypoxia.
  • HIF1alpha-mediated macroautophagy, enhanced by PDGFR signaling, may aid tumor cell survival in hypoxic environments.

Related Concept Videos

Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...